MAPT and frontotemporal dementia: This is the first documented FTD case due to a TBK-1 mutation with in vivo detection of Lewy-body co-pathology using an α-synuclein (αSyn) seed amplification assay (SAA), alongside in vivo longitudinal tau pathology monitoring using tau PET.